1.Linz B, Balloux F, Moodley Y, Manica A, Liu H, Roumagnac P, Falush D, Stamer C, Prugnolle F, van der Merwe SW, Yamaoka Y, Graham DY, Perez-Trallero E, Wadstrom T, Suerbaum S, Achtman M. An African origin for the intimate association between humans and Helicobacter pylori. Nature. 2007 Feb 22;445(7130):915-918. doi: 10.1038/nature05562. Epub 2007 Feb 7. PMID: 17287725; PMCID: PMC1847463.
2. Xie C, Lu NH. Review: clinical management of Helicobacter pylori infection in China. Helicobacter.2015;20(1):1-10. doi:10.1111/hel.12178
3. Leide-Svegborn S, Stenström K, Olofsson M, et al. Biokinetics and radiation doses for carbon-14 urea in adults and children undergoing the Helicobacter pylori breath test. Eur J Nucl Med. 1999;26(6):573-580. doi:10.1007/s002590050424
4. Bentur Y, Matsui D, Koren G. Safety of 14C-UBT for diagnosis of Helicobacter pylori infection in pregnancy. Can Fam Physician. 2009;55(5):479-480.
5. 中华医学会,中华医学会杂志社,中华医学会全科医学分会,中华医学会消化病学分会幽门螺杆菌学组,中华医学会《中华全科医师杂志》编辑..,消化系统疾病基层诊疗指南编写专家组.幽门螺杆菌感染基层诊疗指南(2019年)[J].中华全科医师杂志,2020,19(5):397-402.
6. Grooten IJ, Den Hollander WJ, Roseboom TJ, et al. Helicobacter pylori infection: a predictor of vomiting severity in pregnancy and adverse birth outcome.AmJObstetGynecol.2017;216(5):512.e1-512.e9.doi:10.1016/j.ajog.2017.01.042.
7. Zhan Y, Si M, Li M, Jiang Y. The risk of Helicobacter pylori infection for adverse pregnancy outcomes: A systematic review and meta-analysis. Helicobacter. 2019;24(2):e12562. doi:10.1111/hel.12562
8. Nguyen CT, Davis KA, Nisly SA, Li J. Treatment of Helicobacter pylori in Special Patient Populations. Pharmacotherapy. 2019;39(10):1012-1022. doi:10.1002/phar.2318